Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
08/1995
08/05/1995CA2141907A1 Virus msrvl and pathogen agent and/or msrv2 associated with multiple sclerosis, their nucleic constituants and their applications
08/05/1995CA2141782A1 Triazole derivatives having antimycotic activity
08/03/1995WO1995020664A2 Mammalian expression systems for hepatitis c virus envelope genes
08/03/1995WO1995020660A2 Immunization by inoculation of dna transcription unit
08/03/1995WO1995020659A1 MODIFIED PAPILLOMA VIRUS L2 PROTEIN AND VLPs FORMED THEREFROM
08/03/1995WO1995020658A2 Diagnosis and treatment of infections due to streptococci and enterococci
08/03/1995WO1995020597A1 Modified oligonucleotides
08/03/1995WO1995020595A1 L-nucleosides for the treatment of hepatitis b-virus and epstein-bar virus
08/03/1995WO1995020398A1 Human growth hormone
08/03/1995WO1995020387A1 Method for preventing or reducing photosensitivity and/or phototoxicity reactions to medications
08/03/1995WO1995020320A1 Self-assembling multimeric nucleic acid constructs
08/03/1995CA2182205A1 Human growth hormone
08/03/1995CA2182170A1 Mammalian expression systems for hepatitis c virus envelope genes
08/03/1995CA2180727A1 Modified oligonucleotides
08/02/1995EP0665215A1 1,4-Diamino-2,3-dihydroxybutanes
08/02/1995EP0664834A1 Recombinant humanized anti-cytomegalovirus antibodies
08/02/1995EP0664814A1 Lipopolysaccharide-binding and neutralizing peptides
08/02/1995EP0664779A1 Antibiotic agents
08/02/1995EP0664710A1 NON-PEPTIDYL MOIETY-CONJUGATED CD4-GAMMA2 AND CD4-IgG2 IMMUNOCONJUGATES, AND USES THEREOF
08/02/1995EP0664709A1 Pharmaceutical composition containing an antimicrobial agent and an antibiotic
08/02/1995EP0522030B1 Hepatitis b vaccine
08/02/1995CN1106014A PyridoÛ1,2,3-D,EÙÛ1,3,4Ùbenzoxadiazine derivatives
08/02/1995CN1106006A Crystals of antimicrobial compound
08/01/1995US5438118 Peptide mimics having constrained peptide backbone
08/01/1995US5438069 1,2-dideoxy-2-(hydroxymethyl)-1-(methylamino)-myo-inositol hydrochloride and stereoisomers; for treatment of viral infections and metastatic tumors
08/01/1995US5438052 Cephalosporin derivatives
08/01/1995US5437974 DNA sequence and encoded polypeptide useful in the diagnosis of hepatitis disease
08/01/1995US5437951 A genetic construct comprising a PAPILLOMAVIRUS L1 gene; vaccines, diagnostic kits; genetic engineering
08/01/1995US5437872 Pharmaceutical compositions and a device for administering the same
08/01/1995CA1336492C Treatment of genital warts with a combination of podophyllin and recombinant dna human alpha interferon
08/01/1995CA1336491C Antiviral pharmaceutical composition
07/1995
07/27/1995WO1995020049A1 Herpesvirus pre-(viral dna replication) enveloped
07/27/1995WO1995020048A1 Secretion of proteins from the outer membrane of gram-negative bacteria by gram-positive host organisms
07/27/1995WO1995019983A1 Watersoluble azole antifungals
07/27/1995WO1995019979A1 Improved process for synthesizing carbapenem intermediates
07/27/1995WO1995019957A1 Hydroxamic acid derivatives as metalloproteinase inhibitors
07/27/1995WO1995019784A1 Human therapeutic uses of bpi protein products
07/27/1995WO1995019782A1 Antiviral powder, antiviral extract, and pharmaceutical preparation containing said powder and/or said extract
07/27/1995WO1995019777A2 Use of diesters of muramyl peptides in oral form as immunostimulating agents
07/27/1995WO1995019772A1 Use of bis(amidinobenzimidazoles) in the manufacture of medicament for inhibiting retroviral integrase
07/27/1995WO1995019767A1 Guanylhydrazones for treating inflammatory conditions
07/27/1995WO1995019766A1 Benzalkonium fluoride injectable solution
07/27/1995WO1995019706A1 Inhibitors of fatty acid synthesis as antimicrobial agents
07/27/1995WO1995017511A3 Mycobacteria virulence factors and a method for their identification
07/27/1995WO1995012677A3 Immunodominant human t-cell epitopes of hepatitis c virus
07/27/1995WO1995011975A3 Retroviral superantigens, superantigen peptides, and methods of use
07/27/1995CA2181899A1 Use of diesters of muramyl peptides in oral form as immunostimulating agents
07/27/1995CA2181885A1 Benzalkonium fluoride injectable solution
07/27/1995CA2181816A1 Human therapeutic uses of bpi protein products
07/27/1995CA2181031A1 Inhibitors of fatty acid synthesis as antimicrobial agents
07/27/1995CA2178935A1 Improved process for synthesizing carbapenem intermediates
07/27/1995CA2158652A1 Antiviral powder, antiviral extract, and pharmaceutical preparation containing said powder and/or said extract
07/27/1995CA2126361A1 Gene encoding cationic amino acid transporter protein
07/26/1995EP0664294A1 Production of nucleoside analogues
07/26/1995EP0663916A1 O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants
07/26/1995EP0663902A1 25-carboxylic acid derivatives in the vitamin d series, pharmaceutical preparations containing these derivatives and their use in the manufacture of medicines
07/26/1995EP0663833A1 Royal jelly.
07/26/1995EP0663831A1 Transdermal azidothymidine
07/26/1995EP0663816A1 Novel class of phosphocholine derivatives having antifungal activity
07/26/1995EP0596929B1 Amide derivatives of antibiotic a 40926
07/26/1995CN1105666A Novel diazabicycloalkenes and processes for the preparation thereof
07/26/1995CN1105563A Antibiotic combination
07/25/1995US5436341 Intermediates for 2,3-diamino-1,5-iminosugars
07/25/1995US5436321 Antibodies to the lipopolysaccharide bonding opsonin septin
07/25/1995US5436266 Compounds
07/25/1995US5436253 Pyridonecarboxylic acid derivatives and mycotic infections
07/25/1995US5436234 Eurcyl, brassidyl and nervonyl derivatives
07/25/1995US5436000 Flagella-less borrelia
07/25/1995CA1336430C Therapeutic nucleosides
07/25/1995CA1336412C Pharmaceutical composition having synergistic effect
07/25/1995CA1336411C Veterinary composition containing cloxacillin
07/25/1995CA1336407C Prevention and treatment of retroviral disease
07/25/1995CA1336397C Methyl cellulose pharmaceutical composition
07/20/1995WO1995019438A1 Equine arteritis virus peptides, antibodies and their use in a diagnostic test
07/20/1995WO1995019433A2 Anti-hepatitis b poly- and oligonucleotides
07/20/1995WO1995019429A2 Method and reagent for inhibiting hepatitis c virus replication
07/20/1995WO1995019372A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
07/20/1995WO1995019370A1 Ion-channel forming amphiphilic peptides having n-terminal modifications
07/20/1995WO1995019361A1 Process and intermediates for preparing naphthyridonecarboxylic acid salts
07/20/1995WO1995019180A1 Anti-gram-positive bacterial methods and materials
07/20/1995WO1995019179A1 Anti-fungal methods and materials
07/20/1995WO1995019172A1 Use of n-alkyl derivatives of 1,5-dideoxy-1,5-imino-d-glucitol for the treatment of hepatitis b virus infections
07/20/1995WO1995016696A3 Modified oligonucleotides, method for producing them and use as active substances
07/20/1995WO1995007995A3 Adeno-associated viral (aav) liposomes and methods related thereto
07/20/1995CA2181159A1 Equine arteritis virus peptides, antibodies and their use in a diagnostic test
07/20/1995CA2180748A1 Ion-channel forming amphiphilic peptides having n-terminal modifications
07/20/1995CA2180740A1 Method and reagent for inhibiting hepatitis c virus replication
07/20/1995CA2180347A1 Anti-hepatitis b poly- and oligonucleotides
07/20/1995CA2140408A1 Production of nucleoside analogues
07/19/1995EP0662973A1 Novel cephalosporin derivatives and processes for the preparation thereof
07/19/1995EP0662970A1 Process for the preparation of 2-amino-6-chloropurine
07/19/1995EP0662946A1 Unsaturated aliphatic dicarboxylic acids
07/19/1995EP0662835A1 New pharmaceutical formulations of spiramycine.
07/19/1995EP0662834A1 Novel epoxide-containing compounds
07/19/1995EP0662829A1 Polyamine derivatives as anti-cytomegaloviral agents
07/19/1995EP0662828A1 Trimethoprim oral liquid
07/19/1995EP0527760B1 Methods and compositions for vaccination against hiv
07/19/1995CN1105365A Cephalosporin derivatives
07/19/1995CN1105240A Pharmaceutical composition
07/18/1995US5434140 Antibiotic derivatives
1 ... 1631 1632 1633 1634 1635 1636 1637 1638 1639 1640 1641 1642 1643 1644 1645 1646 1647 1648 1649 1650 1651 ... 1798